Is Gilead Sciences, Inc halal to invest in?

As of August 2026, Gilead Sciences, Inc GILD.VI is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Gilead Sciences, Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Gilead Sciences, Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Gilead Sciences, Inc?

Muslim investors may consider investing in Gilead Sciences, Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Gilead Sciences, Inc classified as HALAL?

Musaffa determines the Shariah status of Gilead Sciences, Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Gilead Sciences, Inc updated?

The Shariah compliance status of Gilead Sciences, Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Gilead Sciences, Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Gilead Sciences, Inc?

You can check the latest Shariah compliance status of Gilead Sciences, Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Gilead Sciences, Inc GILD.VI

Last Updated: Aug 07, 12:00 AM·WBAG

GILD.VI Shariah Compliance

Screening Methodology: AAOIFI

As of August 2026, Gilead Sciences, Inc is classified as halal.

HALAL

Report Source: undefined Quarter Report

Gilead Sciences, Inc. Stock Analysis GILD.VI

Austria Health Care Large Cap

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The company is headquartered in Foster City, California and currently employs 17,000 full-time employees. The company is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. The company is focused on discovering, developing, and delivering medicines to address unmet medical needs in virology, oncology, and other therapeutic areas. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Livdelzi/Lyvdelzi, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada for PrEP, and others. The company also sells and distributes authorized generic versions of Epclusa and Harvoni in the United States through its subsidiary, Asegua Therapeutics LLC. The company has control on anitocabtagene autoleucel (anito cel), an investigational BCMA-directed CAR T cell therapy for multiple myeloma. The company operates in over 35 countries worldwide.